[1]
Shambhavi, S. et al. 2025. Demographic Variations in Immune Checkpoint Inhibitor Adverse Events: A Real-World Study. World Journal of Oncology. 16, 5 (Sep. 2025), 439–445. DOI:https://doi.org/10.14740/wjon2612.